ADAMTS9 and hepatocellular carcinoma: Moreover, Zhang et al. [23] demonstrated that ADAMTS9-AS1 contributed to proliferation, migration, and invasion in hepatocellular carcinoma cells, likely due to the activation of the PI3K/AKT/mTOR signaling pathway.